Property and Equipment, Net (Details) - USD ($) |
12 Months Ended | ||||
|---|---|---|---|---|---|
Dec. 31, 2025 |
May 31, 2025 |
Dec. 31, 2024 |
May 31, 2024 |
Dec. 31, 2023 |
|
| Property and Equipment, Net [Line Items] | |||||
| Depreciation expense | $ 235,827 | $ 1,041,234 | |||
| Impairment loss | |||||
| Gain on disposal of medical equipment | 58,621 | 79,822 | |||
| DiamiR Biosciences Corp. [Member] | |||||
| Property and Equipment, Net [Line Items] | |||||
| Depreciation expense | $ 20,828 | $ 20,052 | |||
| Research and Development Expense [Member] | |||||
| Property and Equipment, Net [Line Items] | |||||
| Impairment loss | 1,421,782 | ||||
| Other Operating Expenses [Member] | |||||
| Property and Equipment, Net [Line Items] | |||||
| Impairment loss | $ 5,520 | $ 28,128 | |||
| X | ||||||||||
- Definition The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|